Clinical Trial Update: Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 safety and immunogenicity study of a Vero cell-derived, whole-virus H5N1 influenza vaccine in healthy infants, children, and adolescents has been comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avian Influenza

Drugs mentioned

• H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) (influenza vaccine, H5N1, vero cell-derived, whole-virus)

Snippet

Sponsor: Alachua Government Services, Inc. | Conditions: Influenza, Avian | Phase 1, Phase 2 | Status: COMPLETED